Pembrolizumab,eftilagimod
novartis,Merck
['head and neck', 'immutep']
immutep reports final positive data in 2nd line head and neck squamous cell carcinoma at asco 2023 annual meeting 
BIO Deutschland ist der Branchenverband der Biotechnologie-Industrie in Deutschland. Impressum: https://t.co/S0KJ3AHBoU